Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)

CompletedOBSERVATIONAL
Enrollment

338

Participants

Timeline

Start Date

March 28, 2019

Primary Completion Date

January 4, 2023

Study Completion Date

January 4, 2023

Conditions
Schizophrenia
Trial Locations (57)

10032

Alkermes Investigational Site, New York

11004

Alkermes Investigational Site, Glen Oaks

11418

Alkermes Investigational Site, Jamaica

12603

Alkermes Investigational Site, Poughkeepsie

14215

Alkermes Investigational Site, Buffalo

19610

Alkermes Investigational Site, Wyomissing

21015

Alkermes Investigational Site, Bel Air

30046

Alkermes Investigational Site, Lawrenceville

30912

Alkermes Investigational Site, Augusta

32308

Alkermes Investigational Site, Tallahassee

32405

Alkermes Investigational Site, Panama City

32803

Alkermes Investigational Site, Orlando

33012

Alkermes Investigational Site, Hialeah

33014

Alkermes Investigational Site, Miami Gardens

33016

Alkermes Investigational Site, Hialeah

33136

Alkermes Investigational Site, Miami

33319

Alkermes Investigational Site, Lauderdale Lakes

37067

Alkermes Investigational Site, Franklin

44122

Alkermes Investigational Site, Beachwood

44145

Alkermes Investigational Site, Westlake

44333

Alkermes Investigational Site, Fairlawn

44691

Alkermes Investigational Site, Wooster

46202

Alkermes Investigational Site, Indianapolis

49008

Alkermes Investigational Site, Kalamazoo

49503

Alkermes Investigational Site, Grand Rapids

57104

Alkermes Investigational Site, Sioux Falls

60194

Alkermes Investigational Site, Schaumburg

62702

Alkermes Investigational Site, Springfield

63118

Alkermes Investigational Site, St Louis

63128

Alkermes Investigational Site, St Louis

63141

Alkermes Investigational Site, St Louis

64083

Alkermes Investigational Site, Raymore

64108

Alkermes Investigational Site, Kansas City

68526

Alkermes Investigational Site, Lincoln

74114

Alkermes Investigational Site, Tulsa

74136

Alkermes Investigational Site, Tulsa

74701

Alkermes Investigational Site, Durant

76104

Alkermes Investigational Site, Fort Worth

76306

Alkermes Investigational Site, Wichita Falls

77074

Alkermes Investigational Site, Houston

77407

Alkermes Investigational Site, Richmond

78229

Alkermes Investigational Site, San Antonio

78746

Alkermes Investigational Site, Austin

84105

Alkermes Investigational Site, Salt Lake City

85719

Alkermes Investigational Site, Tucson

91334

Alkermes Investigational Site, Granada Hills

91402

Alkermes Investigational Site, Panorama City

92021

Alkermes Investigational Site, El Cajon

92054

Alkermes Investigational Site, Oceanside

92404

Alkermes Investigational Site, San Bernardino

92626

Alkermes Investigational Site, Costa Mesa

96817

Alkermes Investigational Site, Honolulu

96826

Alkermes Investigational Site, Honolulu

97401

Alkermes Investigational Site, Eugene

06241

Alkermes Investigational Site, Dayville

02114

Alkermes Investigational Site, Boston

03101

Alkermes Investigational Site, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alkermes, Inc.

INDUSTRY